These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26163148)

  • 1. FBXW7 overexpression suppresses renal cancer cell proliferation and induces apoptosis.
    Fu Y; Lin Y; Yang Z; Yang G; Li G; Liu Y; Tan X; Huang Y; Wu X; Wang Y; Xiong H; Zhang M; Fang L; Ge Y; Zeng J; Cai Y; Bai J; Wu S
    Med Oncol; 2015 Aug; 32(8):215. PubMed ID: 26163148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.
    Tu K; Yang W; Li C; Zheng X; Lu Z; Guo C; Yao Y; Liu Q
    Mol Cancer; 2014 May; 13():110. PubMed ID: 24884509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FBXW7 acts as an independent prognostic marker and inhibits tumor growth in human osteosarcoma.
    Li Z; Xiao J; Hu K; Wang G; Li M; Zhang J; Cheng G
    Int J Mol Sci; 2015 Jan; 16(2):2294-306. PubMed ID: 25622249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4.
    Li J; Guo Y; Liang X; Sun M; Wang G; De W; Wu W
    J Cancer Res Clin Oncol; 2012 May; 138(5):763-74. PubMed ID: 22270966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FBXW7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: A single-center retrospective study.
    Arita H; Nagata M; Yoshida R; Matsuoka Y; Hirosue A; Kawahara K; Sakata J; Nakashima H; Kojima T; Toya R; Murakami R; Hiraki A; Shinohara M; Nakayama H
    Tumour Biol; 2017 Oct; 39(10):1010428317731771. PubMed ID: 29072128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of Fbxw7 and its correlation with cell proliferation in human hepatocellular carcinoma].
    Zhou ZY; Tu KS; Zhang J; Zheng X; Gao J; Yao YM; Liu QG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Dec; 28(12):1303-6. PubMed ID: 23232523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-367 promotes the proliferation and invasion of non-small cell lung cancer via targeting FBXW7.
    Xu J; Wu W; Wang J; Huang C; Wen W; Zhao F; Xu X; Pan X; Wang W; Zhu Q; Chen L
    Oncol Rep; 2017 Feb; 37(2):1052-1058. PubMed ID: 28000899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
    Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
    Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.
    Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF
    Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma.
    Yokobori T; Mimori K; Iwatsuki M; Ishii H; Tanaka F; Sato T; Toh H; Sudo T; Iwaya T; Tanaka Y; Onoyama I; Kuwano H; Nakayama KI; Mori M
    Int J Oncol; 2012 Jul; 41(1):253-9. PubMed ID: 22576686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E.
    Tu K; Zheng X; Zhou Z; Li C; Zhang J; Gao J; Yao Y; Liu Q
    PLoS One; 2013; 8(7):e68574. PubMed ID: 23840897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance.
    Iwatsuki M; Mimori K; Ishii H; Yokobori T; Takatsuno Y; Sato T; Toh H; Onoyama I; Nakayama KI; Baba H; Mori M
    Int J Cancer; 2010 Apr; 126(8):1828-1837. PubMed ID: 19739118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients.
    Ibusuki M; Yamamoto Y; Shinriki S; Ando Y; Iwase H
    Cancer Sci; 2011 Feb; 102(2):439-45. PubMed ID: 21134077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FBXW7 beta-form is suppressed in human glioma cells.
    Gu Z; Inomata K; Ishizawa K; Horii A
    Biochem Biophys Res Commun; 2007 Mar; 354(4):992-8. PubMed ID: 17274947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of FBXW7 in esophageal squamous cell carcinoma and its clinical significance].
    Yu H; Ling T; Shi R; Shu Q; Li Y; Tan Z
    Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):347-51. PubMed ID: 26463024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RASA1 inhibits the progression of renal cell carcinoma by decreasing the expression of miR-223-3p and promoting the expression of FBXW7.
    Zhang RL; Aimudula A; Dai JH; Bao YX
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32588875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fbxw7/hCdc4 tumor suppressor in human cancer.
    Tan Y; Sangfelt O; Spruck C
    Cancer Lett; 2008 Nov; 271(1):1-12. PubMed ID: 18541364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion.
    He D; Huang C; Zhou Q; Liu D; Xiong L; Xiang H; Ma G; Zhang Z
    Oncotarget; 2017 Mar; 8(12):20165-20178. PubMed ID: 28423622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-24 promotes the proliferation, migration and invasion in human tongue squamous cell carcinoma by targeting FBXW7.
    Zhao J; Hu C; Chi J; Li J; Peng C; Yun X; Li D; Yu Y; Li Y; Gao M; Zheng X
    Oncol Rep; 2016 Aug; 36(2):1143-9. PubMed ID: 27350307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
    Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
    Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.